CONMED CORPORATION (CNMD) FY2026 Q2 Statement of Cash Flows
2026-04-01 to 2026-06-30
Statement of Cash Flows
2026-04-01 to 2026-06-30
Swipe to see the full flow
Chart details
CONMED CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026
Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Mar 31, 2026
- 35,030,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 37,095,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Gain on sale of a product line), so Gain on sale of product offerings, net and (Gain) loss on early extinguishment of debt, net cannot be separated for this quarter. It may combine inflows and outflows.
- Net income
- 23,071,000 US dollars
- Depreciation
- 4,079,000 US dollars
- Amortization of deferred debt issuance costs
- 1,054,000 US dollars
- Amortization
- 14,967,000 US dollars
- Stock-based compensation
- 5,230,000 US dollars
- Deferred income taxes
- 2,148,000 US dollars
- Non-cash adjustments to fair value of contingent consideration liability
- negative 112,000 US dollars
- Accounts receivable
- negative 11,351,000 US dollars
- Inventories
- negative 1,437,000 US dollars
- Accounts payable
- negative 4,248,000 US dollars
- Accrued compensation and benefits
- 9,447,000 US dollars
- Other assets
- 532,000 US dollars
- Other liabilities
- negative 4,092,000 US dollars
- Remaining operating cash flows, net (calculated)
- negative 2,193,000 US dollars
- Investing activities
- 11,566,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the investing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Proceeds from sale of a product line), so Proceeds from sale of product offerings cannot be separated for this quarter. It may combine inflows and outflows.
- Purchases of property, plant and equipment
- negative 2,934,000 US dollars
- Other
- 0 US dollars
- Remaining investing cash flows, net (calculated)
- 14,500,000 US dollars
- Financing activities
- negative 46,234,000 US dollars. Net cash used.
- Payments on term loan
- 0 US dollars
- Proceeds from term loan
- 450,000,000 US dollars
- Payments on revolving line of credit
- negative 247,000,000 US dollars
- Proceeds from revolving line of credit
- 415,000,000 US dollars
- Repurchases of common stock
- negative 6,204,000 US dollars
- Payments to repurchase convertible notes
- negative 637,176,000 US dollars
- Payments related to contingent consideration
- negative 17,489,000 US dollars
- Payments related to debt issuance costs
- negative 3,547,000 US dollars
- Dividends paid on common stock
- 0 US dollars
- Other, net
- 182,000 US dollars
- Operating adjustment reconciliation
- 37,457,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- financing gross reconciliation
- 911,416,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing displayed reconciliation
- 14,500,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- Exchange-rate effect
- negative 129,000 US dollars
- Ending cash on Jun 30, 2026
- 37,328,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 83,691,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 2,298,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 1.61×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- Operating cash flow
- 37,095,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 2,934,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 34,161,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $14.02M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 37,095,000 US dollars minus 2,934,000 US dollars equals 34,161,000 US dollars.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
